Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Helen Leis

Partner, Health & Life Sciences, Oliver Wyman

Returning to work, school, and daily life in a recovering economy means co-existing with COVID-19.

Partner, Health & Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner and Co-Lead of Digital Transformation, EMEA, Oliver Wyman
Partner and Chief Medical Officer, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Q&A with a Pandemic Response Expert

How COVID-19 testing, contact tracing, and targeted quarantine may revive consumer and employee confidence.

Partner, Health & Life Sciences, Oliver Wyman

As parts of the nation begin to re-open, new considerations are unfolding that leaders struggle to manage.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Key takeaways for navigating COVID-19 as lockdowns are lifted and economies are reopened.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Businesses must prepare now for the long haul of COVID-19 suppression if they are to survive in a changed economy.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner and Co-Lead of Digital Transformation, EMEA, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Evaluating healthcare workforce supply and demand.

Partner and Chief Medical Officer, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

When COVID-19 is Found in Your Area, What’s Your Game Plan?

Important considerations for all healthcare providers navigating the effects of coronavirus.

Partner and Chief Medical Officer, Health and Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Men hold most (87 percent) of C-suite roles at healthcare’s top ranks. But why?

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

What the future may hold for four big company names looking to become big names in healthcare.

Partner, Health & Life Sciences, Oliver Wyman

Shifting demand will change the nature of work in healthcare.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Senior Workforce Strategy Consultant, Mercer

Insights in your inbox

Subscribe